Loading stock data…
Alcon Inc. (ALC)
$69.12-1.38 (-1.96%)
After Hours$69.12+0.00 (+0.00%)· Last close Sep 8
Alcon Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Alcon Inc. in the Healthcare sector is trading at $69.12 with a market capitalization of $31.3B. Wall Street consensus targets $85.24 (15 analysts), implying a +23.3% move over the next 12 months. The stock is currently 21% below its 52-week high of $87.64, remaining 6.9% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 24 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +23.3% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 24) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $2.71B↓ | $2.72B↑ | $2.61B↑ | $2.60B↑ | $2.47B |
| Gross Profit | $1.52B↑ | $1.52B↑ | $1.46B↑ | $1.39B↑ | $1.38B |
| Operating Income | $292.00M↓ | $313.00M↓ | $332.00M↑ | $247.00M↓ | $468.00M |
| Net Income | $189.00M↓ | $217.00M↓ | $237.00M↑ | $176.00M↓ | $350.00M |
Peer Comparison
JNJUNHPFE
Fundamentals
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), a...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$31.32B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
38.46
Beta
Defensive asset. Lower volatility than the S&P 500.
0.70
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.52%
ROE
Average efficiency. Growth may require heavy reinvestment.
3.70%
Volume
Today's trading volume
1.65M
Recent News
Here's How Trump's Drug Deals Are Likely to Impact Healthcare ETFs
Trump's latest MFN drug-pricing deals create a mixed outlook for the broader healthcare sector ETFs.
Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now?
Alcon's acquisitions, partnerships and new product launches support growth, but tariffs and intense competition remain key risks.
Are Options Traders Betting on a Big Move in Alcon Stock?
Investors need to pay close attention to ALC stock based on the movements in the options market lately.
Alcon (SWX:ALC), What Is Behind The Fresh Attention?
Alcon stock reacts to US Medicaid drug pricing agreement New US Medicaid drug pricing agreements involving Alcon (SWX:ALC) and eight other healthcare companies have put the stock in focus for investors assessing potential implications for its eye care drug portfolio. At around CHF58.30 per share, Alcon has seen short term share price pressure related to the Medicaid headlines, with the 1-day share price return down 0.44% and the year-to-date share price return down 8.25%. In contrast, the...
Trump's MFN Push Goes Beyond Big Pharma, Adds 9 Mid-Sized Drugmakers
Trump's MFN push expands to nine mid-sized drugmakers, bringing 26 companies under agreements covering 89% of the branded drug market.